![]() |
市場調查報告書
商品編碼
1625185
到 2030 年自動縫合設備市場預測:按產品類型、技術、分銷管道、應用、最終用戶和地區進行的全球分析Automated Suturing Devices Market Forecasts to 2030 - Global Analysis By Product Type, Technology, Distribution Channel, Application, End User and By Geography |
根據Stratistics MRC預測,2024年全球自動縫合設備市場規模將達35億美元,預計在預測期內複合年成長率為9.4%,到2030年將達到60億美元。
自動縫合設備是先進的手術器械,旨在實現各種醫療手術中縫合過程的自動化。這些設備包括允許精確縫合組織、減少人為錯誤並提高手術效率的機制。自動縫合裝置有一次性和可重複使用兩種類型,應用範圍廣泛,從普通外科到心臟、胸腔外科和胃腸外科等專業領域。
根據世界衛生組織估計,全球約有119萬人死於交通事故,2,000萬至5,000萬人遭受非致命傷害。
微創手術需求不斷成長
對微創手術(MIS)的日益偏好是推動自動縫合設備市場成長的主要因素。隨著患者和醫療保健提供者尋求切口更小、疤痕更少、恢復時間更快和感染風險更低的手術,MIS 變得越來越受歡迎。自動縫合設備在這些手術中發揮關鍵作用,可以提高準確性、減少人為錯誤並簡化縫合過程。透過提高效率和加速傷口縫合,這些設備有助於 MIS 的成功。隨著微創手術的全球趨勢持續成長,對自動化縫合解決方案的需求預計將會增加。
培訓和技能需求
對專業培訓和技能的需求是自動縫合設備市場的主要挑戰。這些設備提高了準確性和效率,但需要醫療保健專業人員(尤其是外科醫生)進行專門培訓才能有效操作。訓練不足可能會導致手術過程中表現不佳和出現錯誤。此外,醫院和手術中心必須投入時間和資源來培訓員工,這可能會延遲新技術的實施。這些熟練人員的要求可能會阻礙自動縫合技術的廣泛使用,特別是在資源匱乏的地區。
新興市場醫療保健基礎設施的成長
新興市場醫療保健基礎設施的擴張推動了對自動縫合設備的需求。隨著中東、亞太和拉丁美洲國家投資現代化和擴大其醫療保健系統,先進的醫療技術變得越來越必要。隨著醫療機構努力提高業務效率、縮短恢復時間並改善手術效果,自動縫合設備變得越來越受歡迎。外科手術數量的增加和微創技術知識的增加進一步加速了這些設備的採用並推動了新興國家的市場擴張。
初始成本高
自動縫合設備的高昂初始成本是廣泛採用的主要障礙,特別是在資源匱乏的環境中。由於初始成本高昂,先進設備,特別是機器人輔助縫合系統,對於開發中國家的小型診所、醫院和醫療機構來說是遙不可及的。由於維護、培訓和滅菌要求較高,整體成本可能會增加。儘管這些技術在準確性和效率方面具有長期優勢,但其初始成本可能會阻止醫療相關人員將其納入外科手術中,並可能限制某些市場的市場擴張。
COVID-19 的影響
COVID-19大流行對自動縫合設備市場產生了重大影響。最初,隨著擇期手術被推遲以優先治療 COVID-19 患者,對這些設備的需求下降。然而,隨著疫情的發展,由於與 COVID-19併發症相關的手術數量增加,以及為降低感染風險而採用微創手術的情況增多,對這些設備的需求增加。此外,疫情也加速了自動縫合設備等先進技術的採用,以提高效率並降低接觸病毒的風險。
普通外科預計將成為預測期內最大的細分市場
由於需要提高準確性、減少手術時間和改善患者治療效果,一般外科領域估計是最大的。這些設備提供更快、更一致的縫合,這在疝氣修復、闌尾和膽囊手術等常規手術中尤其有價值。此外,人們越來越關注需要精確組織閉合的微創手術,導致更多地採用自動縫合設備,從而提高手術效率並降低併發症率。
研究機構領域預計在預測期內複合年成長率最高
研究機構部門預計在預測期內將出現最高的複合年成長率,因為它負責推進外科技術和技術。這些研究機構特別專注於開發自動縫合設備在複雜和專業手術中的新應用。此外,與醫療設備製造商的合作推動了臨床研究,以確保自動縫合設備滿足不斷變化的手術需求並有助於改善患者的治療效果。
由於醫療基礎設施的快速進步、手術數量的增加以及微創手術 (MIS) 的採用不斷增加,預計亞太地區在預測期內將佔據最大的市場佔有率。隨著中國、印度和日本等國家投資現代化醫療保健系統,先進手術技術的需求不斷增加。此外,該地區人口眾多且老化,以及醫療創新的普及,刺激了對自動縫合設備等精確高效手術器械的需求,進一步推動了馬蘇市場的成長。
預計北美地區在預測期內的複合年成長率最高。這是由於先進的醫療基礎設施、微創手術 (MIS) 的高採用率以及對精準手術的日益關注。該地區人口老化和外科手術數量的增加進一步增加了對高效可靠縫合解決方案的需求。此外,領先醫療設備製造商的存在、機器人輔助手術技術創新的增加以及醫療保健支出的增加都有助於市場成長,使北美成為自動縫合設備的關鍵市場。
According to Stratistics MRC, the Global Automated Suturing Devices Market is accounted for $3.50 billion in 2024 and is expected to reach $6.00 billion by 2030 growing at a CAGR of 9.4% during the forecast period. Automated suturing devices are advanced surgical tools designed to automate the suturing process during various medical procedures. These devices are equipped with mechanisms that enable precise stitching of tissues, reducing human error and enhancing surgical efficiency. Automated suturing devices can be disposable or reusable, and are employed in applications ranging from general surgery to specialized fields like cardiothoracic and gastrointestinal surgery.
According to WHO estimates approximately 1.19 million people die due to road traffic crashes, and between 20 and 50 million more suffer non-fatal injuries globally.
Growing demand for minimally invasive surgeries
The increasing preference for minimally invasive surgeries (MIS) is a key factor driving the growth of the automated suturing devices market. As patients and healthcare providers seek procedures that offer smaller incisions, reduced scarring, quicker recovery times, and lower risk of infection, MIS has gained widespread popularity. Automated suturing devices play a critical role in these procedures, enhancing precision, reducing human error, and streamlining the suturing process. By improving efficiency and enabling faster wound closure, these devices contribute to the success of MIS. As the global trend toward minimally invasive procedures continues to grow, it is expected that demand for automatic suturing solutions will increase.
Training and skill requirements
The need for specialized training and skills poses a considerable challenge in the automated suturing devices market. While these devices offer enhanced precision and efficiency, they require healthcare professionals, particularly surgeons, to undergo specialized training to operate them effectively. Inadequate training may lead to suboptimal performance or errors during procedures. Furthermore, hospitals and surgical centers must invest time and resources in training staff, which can delay the adoption of new technologies. This requirement for skilled personnel may hinder the widespread use of automated suturing technology, particularly in areas with low resources.
Healthcare infrastructure growth in emerging markets
The need for automated suturing devices is being driven by the expansion of healthcare infrastructure in emerging markets. Advanced medical technology are becoming more and more necessary as nations in the Middle East, Asia-Pacific, and Latin America make investments to modernize and expand their healthcare systems. As medical facilities strive to increase operational efficiency, decrease recuperation times, and improve surgical results, automated suturing devices are becoming more and more popular. Further accelerating up the adoption of these devices and promoting market expansion in emerging nations are the increasing number of surgical procedures and increased knowledge of minimally invasive techniques.
High initial cost
The substantial upfront cost of automated suturing devices poses a major obstacle to their widespread adoption, particularly in resource-limited environments. Due to their high upfront costs, advanced devices especially robotic-assisted suturing systems are less affordable for smaller clinics, hospitals, and healthcare facilities in developing nations. The overall cost may be increased by the high cost of maintenance, training, and sterilization requirements. Although these technologies have long-term advantages in terms of accuracy and efficiency, the initial cost might deter medical professionals from incorporating them into their surgical procedures, which might hinder market expansion in certain markets.
Covid-19 Impact
The COVID-19 pandemic significantly impacted the automated suturing devices market. Initially, the demand for these devices decreased due to the postponement of elective surgeries to prioritize COVID-19 patient care. However, as the pandemic progressed, the demand for these devices increased due to the rising number of surgeries related to COVID-19 complications and the increasing adoption of minimally invasive surgeries to reduce the risk of infection. Additionally, the pandemic accelerated the adoption of advanced technologies, including automated suturing devices, to improve efficiency and reduce the risk of exposure to the virus.
The general surgery segment is expected to be the largest during the forecast period
The general surgery segment is estimated to be the largest, due to the need for enhanced precision, reduced surgical time, and improved patient outcomes. These devices offer faster and more consistent suturing, which is especially valuable in routine procedures such as hernia repairs, appendectomies, and gallbladder surgeries. Additionally, the increasing focus on minimally invasive techniques, which require precise tissue closure, has led to greater adoption of automated suturing devices, improving surgical efficiency and reducing complication rates.
The research institutions segment is expected to have the highest CAGR during the forecast period
The research institutions segment is anticipated to witness the highest CAGR during the forecast period, due to their role in advancing surgical technologies and techniques. These institutions are focused on exploring new applications for automated suturing devices, particularly in complex or specialized surgeries. Additionally, research collaborations with medical device manufacturers help to drive clinical studies, ensuring that automated suturing devices meet evolving surgical needs and contribute to better patient outcomes.
Asia Pacific is expected to have the largest market share during the forecast period due to rapid advancements in healthcare infrastructure, rising surgical volumes, and increasing adoption of minimally invasive surgery (MIS). As countries like China, India, and Japan invest in modernizing their healthcare systems, there is growing demand for advanced surgical technologies. Additionally, the region's large and aging population, along with improving access to medical innovations, fuels the need for precise, efficient surgical tools like automated suturing devices, further driving market growth.
During the forecast period, the North America region is anticipated to register the highest CAGR, driven by advanced healthcare infrastructure, high adoption of minimally invasive surgeries (MIS), and a growing focus on precision surgery. The region's aging population and increasing incidence of surgical procedures further boost demand for efficient and reliable suturing solutions. Additionally, the strong presence of leading medical device manufacturers, ongoing innovations in robotic-assisted surgeries, and higher healthcare spending contribute to the market's growth, positioning North America as a key market for automated suturing devices.
Key players in the market
Some of the key players profiled in the Automated Suturing Devices Market include Medtronic, Stryker Corporation, Smith & Nephew, B. Braun Melsungen AG, Intuitive Surgical, ConMed Corporation, KARL STORZ GmbH & Co. KG, Applied Medical Resources Corporation, Teleflex Incorporated, Toshiba Medical Systems Corporation, Zimmer Biomet, Boston Scientific, Cook Medical, Inovio Pharmaceuticals, 3M, LivaNova PLC, and Hoya Corporation.
In April 2021, Medtronic announced its partnership with Surgical Theater, a startup that markets a Surgery Rehearsal Platform. With the initiative, the companies focused on integrating SynAR's augmented reality of Surgical Theater with Medtronic's StealthStation S8 surgical navigation system.
In September 2020, Smith &Nephew launched Healicoil Knotless Suture Anchor, an addition to its range of modern healing technology for rotator cuff treatment.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.